Effects of cigarette smoking on reward responsivity and cognitive function in brain injured individuals

Neuropsychological Rehabilitation

Volumn 13, Issue 3, 2003, Pages 365-378

  Richardson, Matt ^a   Powell, Jane H ^b   Curran, H Valerie ^c  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR; BRAIN INJURY; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; MALE; MOTIVATION; NEUROPSYCHOLOGICAL TEST; REWARD; SMOKING CESSATION; TASK PERFORMANCE; VERBAL COMMUNICATION; WORKING MEMORY;

EID: 0038122972     PISSN: 09602011     EISSN: None     Source Type: Journal    
DOI: 10.1080/09602010343000011     Document Type: Article

References (32)

1. Al-Adawi, S. (1998). The neuropsychopharmacology of motivation: An examination of reward and frontal-subcortical mechanisms and functions. PhD Thesis. University of London.
2. Al-Adawi, S., & Powell, J. (1997). The influence of smoking on reward responsiveness and cognitive functions: A natural experiment. Addiction, 92, 1773-1782.
3. Ashton, H. (1992). Brain function and psychotropic drugs. Oxford: Oxford University Press.
4. Benton, A. L., & Hamsher, K. de S. (1989). Multilingual Aphasia Examination. Iowa City: AJA Associates.
5. Blake, J., & Smith, A. (1997). Effects of smoking and smoking deprivation on the articulatory loop of working memory. Human Psychopharmacology: Clinical and Experimental, 12, 259-264.
6. 2 stimulation and blockade on smoking behaviour. Experimental and Clinical Psychopharmacology, 7, 72-78.
7. Dawe, S., Gerada, C., Russell, M. A., & Gray, J. A. (1995). Nicotine intake in smokers increases following a single dose of haloperidol. Psychopharmacology, 117, 110-115.
8. Fowler, J. S., Volkow, M. D., Wang, G. J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Wolf, A. P., Warner, D., Cilento, R., & Zezulkova, I. (1998). Neuropharmacological actions of cigarette smoke: Brain monoamine oxidase (MAO B) inhibition. Journal of Addictive Diseases, 17, 23-34.
9. Gamberino, W. C., & Gold, M. S. (1999). Neurobiology of tobacco smoking and other addictive disorders. Psychiatric Clinics of North America, 22, 301-312.
10. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127.
11. Hughes, J. R., & Hatsukami, D. K. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, 289-294.
12. Jahanshahi, M., & Frith, C. D. (1998). Willed action and its impairments. Cognitive Neuropsychology, 15, 483-533.
13. Kassel, J. D. (1997). Smoking and attention: A review and reformulation of the stimulus-filter hypothesis. Clinical Psychology Review, 17, 451-478.
14. Levi-Minzi, S., Bermanzohn, P. C., & Siris, S. G. (1991). Bromocriptine for negative schizophrenia. Comparative Psychiatry, 32, 210-216.
15. Levin, E. D., & Rose, J. E. (1995). Acute and chronic nicotinic interactions with dopamine systems and working memory performance. Annals of the New York Academy of Science, 757, 245-252.
16. McDowell, S., Whyte, J., & D'Esposito, M. (1998). Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain, 121, 1155-1164.
17. McNair, D. M., Lorr, M., & Droppleman, L. F. (1971). Manual for the Profile of Mood States. San Diego: Educational and Industrial Testing Service.
18. Mehta, M. A., Owen, A. M., Sahakian, B. J., Mavaddat, N., Pickard, J. D., & Robbins, T. W. (2000). Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. Journal of Neuroscience, 20, 1-6.
19. Powell, J. H., Al-Adawi, S., Morgan, J., & Greenwood, R. J. (1996). Motivational deficits after brain injury: Effects of bromocriptine in 11 patients. Journal of Neurology, Neurosurgery and Psychiatry, 66, 416-421.
20. Powell, J. H., Dawkins, L. E., & Davis, R. (2002). Smoking, desire, and planfulness: Tests of an incentive motivational model. Biological Psychiatry, 51, 151-163.
21. Raven, J., Raven, J. C., & Court, J. H. (1998). Raven's Coloured Progressive Matrices and Vocabulary Scales. Oxford: Oxford Psychologist's Press.
22. Rusted, J. M., & Warburton, D. M. (1991). Molecules for modeling cognitive impairment. In I. Hindmarch, H. Hippius, & G. Wilcock (Eds.), Dementia: Molecules, methods and measures. Chichester: Wiley.
23. Shimamura, A. P., Salmon, D. P., Squire, L. R., & Butters, N. (1987). Memory dysfunction and word priming in dementia and amnesia. Behavioural Neuroscience, 101, 347-351
24. Snaith, R. P., Hamilton, M., Morley, S., Humayan, A., Hargreaves, D., & Trigwell, P. (1995). A scale for the assessment of hedonic tone: The Snaith-Hamilton Pleasure Scale. British Journal of Psychiatry, 167, 99-103.
25. Snaith, R. P., & Zigmond, A. S. (1994). The Hospital Anxiety and Depression Scale Manual. Windsor: NFER-Nelson.
26. US Department of Health and Human Services (1988). The health consequences of smoking: Nicotine addiction. Report of the Surgeon General (CDC 89-8411). Washington DC: US Government Printing Office.
27. 2 receptor levels. American Journal of Psychiatry, 156, 19-26.
28. Warburton, D. M., Skinner, A., & Martin, C. D. (2001). Improved incidental memory with nicotine after semantic processing, but not after phonological processing. Psychopharmacology, 153, 258-263.
29. Watanabe, M. D., Martin, E. M., DeLeon, O. A., Gaviria, M., Pavel, D. G., & Trepashko, D. W. (1995). Successful methyphenidate treatment of apathy after subcortical infarcts. Journal of Neuropsychiatry, 7, 502-504.
30. Wechsler, D. (1981). Wechsler Adult Intelligence Scale - Revised. New York: The Psychological Corporation.
31. Weddell, R. A., & Weiser, R. (1995). A double-blind cross-over placebo-controlled trial of the effects of bromocriptine on psychomotor function, cognition, and mood in de novo patients with Parkinson's disease. Behavioural Pharmacology, 6, 81-91.
32. West, R. (1993). Beneficial effects of nicotine: Fact or fiction? Addiction, 88, 589-590.